The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
MOC is a rare histotype of epithelial ovarian cancer, and current management options are inadequate for the treatment of late stage or recurrent disease. A shift towards personalised medicines in ovarian cancer is being observed, with trials targeting specific molecular pathways, however, MOC lags d...
Guardado en:
Autores principales: | Arkan Youssef, Mohammad B. Haskali, Kylie L. Gorringe |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0791ac7552304fc39602d787ea7987a2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
por: Robert L. Hollis, et al.
Publicado: (2021) -
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients
por: Wan-Ru Chao, et al.
Publicado: (2021) -
Clinical significance of mucinous component in colorectal adenocarcinoma: a propensity score-matched study
por: Chuanwang Yan, et al.
Publicado: (2021) -
An Immunohistochemical Evaluation of Tumor-Associated Glycans and Mucins as Targets for Molecular Imaging of Pancreatic Ductal Adenocarcinoma
por: Ruben D. Houvast, et al.
Publicado: (2021) -
Nano-Based Drug Delivery and Targeting to Overcome Drug Resistance of Ovarian Cancers
por: Melayshia McFadden, et al.
Publicado: (2021)